Detection of p16 gene deletions in gliomas: A comparison of fluorescence in situ hybridization (FISH) versus quantitative PCR

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 9, 1997, Pages 999-1008

  Perry, Arie ^a   Nobori, Tsutomu ^b   Ru, Ning ^a   Anderl, Kari ^a   Borell, Thomas J ^a   Mohapatra, Gayatry ^c   Feuerstein, Burt G ^c   Jenkins, Robert B ^a   Carson, Dennis A ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Astrocytoma; Comparative genomic hybridization; Cyclin dependent kinases; Fluorescence in situ hybridization; p16 gene; Polymerase chain reaction; Retinoblastoma genes

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; RETINOBLASTOMA PROTEIN;

ANEUPLOIDY; ARTICLE; ASTROCYTOMA; CELL CYCLE; CONTROLLED STUDY; COSMID; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE DOSAGE; GLIOMA; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; TETRAPLOIDY; TUMOR SUPPRESSOR GENE;

EID: 0030929534     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199709000-00005     Document Type: Article

References (50)

1. von Deimling A, Louis DN, Wiestler OD. Molecular pathways in the formation of gliomas. GLIA 1995;15:328-38
2. Collins VP. Genetic alterations in gliomas. J Neuro-Oncol 1995;24: 37-38
3. Dalrymple SJ, Jenkins RB. Molecular genetics of astrocytomas and meningiomas. Curr Opin Neurol 1994;7:477-83
4. Rey JA, Bello MJ, de Campos JM, Kusak ME, Ramos C, Benitez J. Chromosomal patterns in human malignant astrocytomas. Cancer Genet Cytogenet 1987;29:201-21
5. Bigner SH, Mark J, Burger PC, et al. Specific chromosomal abnormalities in malignant human gliomas. Cancer Res 1988;88:405-11
6. Jenkins RB, Kimmel DW, Moertel CA, et al. A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet 1989;39:253-79
7. Thiel G, Losanowa T, Kintzel D, et al. Karyotypes in 90 human gliomas. Cancer Genet Cytogenet 1992;58:109-20
8. Bello MJ, de Campos JM, Vaquero J, et al. Molecular and cytogenetic analysis of chromosome 9 deletions in 75 malignant gliomas. Genes Chrom Cancer 1994;9:33-41
9. Olopade OI, Jenkins RB, Ransom DT, et al. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res 1992;52:2523-29
10. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264:436-40
11. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994;368:753-56
12. Ueki K, Rubio M-P, Ramesh V, et al. MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet 1994;3:1841-45
13. Schmidt EE, Ichimura K, Reifenberger G, Collins VP. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res 1994;54:6321-24
14. Olopade OI, Pomykala HM, Hagos F, et al. Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21. Proc Natl Acad Sci USA 1995;92: 6489-93
15. Jen J, Harper JW, Bigner SH, et al. Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994;54:6353-58
16. Moulton T, Samara G, Chung W-Y, et al. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Am J Pathol 1995;146: 613-19
17. Li Y-J, Hoang-Xuan K, Delattre J-Y, Poisson M, Thomas G, Hamelin R. Frequent loss of heterozygosity on chromosome 9, and low incidence of mutations of cyclin-dependent kinase inhibitors p15 (MTS2) and p16 (MTS1) genes in gliomas. Oncogene 1995; 11:597-600
18. Sonoda Y, Yoshimoto T, Sekiya T. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Oncogene 1995;11:2145-49
19. INK4B/MTS2 genes in glioma cells and primary glioma tissues. Cancer Letters 1995; 97:241-47
20. Tenan M, Benedetti S, Finocchiaro G. Deletion and transfection analysis of the p15/MTS2 gene in malignant gliomas. Biochem Biophys Res Comm 1995;217:195-202
21. Arap W, Nishikawa R, Furnari FB, Cavenee WK, Huang SH-J. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 1995;55:1351-54
22. Fueyo J, Gomez-Manzano C, Yung WKA, et al. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene 1996;12:103-10
23. He J, Allen JR, Collins VP, et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res 1994;54:5804-7
24. INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res 1995;55:4833-36
25. Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 1996;56:150-53
26. Walker DG, Duan W, Popovic EA, Kaye AH, Tomlinson FH, Lavin M. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res 1995;55: 20-23
27. Dreyling MH, Bohlander SK, Adeyanju MO, Olopade OI. Detection of CDKN2 deletions in tumor cell lines and primary glioma by interphase fluorescence in situ hybridization. Cancer Res 1995; 55:984-88
28. INK4 expression is frequent in high grade gliomas. Cancer Res 1995;55:1941-45
29. INK4 gene in human glioma cells. Oncogene 1996; 12:2029-34
30. Ono Y, Tamiya T, Ichikawa T, et al. Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. J Neuropathol Exp Neurol 1996;55:1026-31
31. Giani C, Finocchiaro G. Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res 1994;54:6338-39
32. Kyritsis AP, Zhang B, Zhang W, et al. Mutations of the p16 gene in gliomas. Oncogene 1996;12:63-67
33. Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1995; 1:686-92
34. INK4B1. Cancer Res 1996;56:722-27
35. Costello JF, Berger MS, Huang SH-J, Cavenee WK. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Cancer Res 1996;56:2405-10
36. Venter DJ, Bevan KL, Ludwig RL, et al. Retinoblastoma gene deletions in human glioblastomas. Oncogene 1991;6:445-48
37. Henson JW, Schnitker BL, Correa KM, et al. The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994;36:714-21
38. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 1994;54:4299-4303
39. Collins VP Gene amplification in human gliomas. GLIA 1995;15: 289-96
40. Nobori T, Karras JG, Della Ragione F, Waltz TA, Chen PP, Carson DA. Absence of methylthioadenosine phosphorylase in human gliomas. Caner Res 1991;51:3193-97
41. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. World Health Organization. Berlin: Springer-Verlag, 1993
42. Dalrymple SJ, Herath JF, Ritland SR, Moertel CA, Jenkins RB. Use of fluorescence in situ hybridization to detect loss of chromosome 10 in astrocytomas. J Neurosurg 1995;83:316-23
43. Dalrymple SJ, Herath JF, Borell TJ, Moertel CA, Jenkins RB. Correlation of cytogenetic and fluorescence in situ hybridization (FISH) studies in normal and gliotic brain. J Neuropathol Exp Neurol 1994; 53:448-56
44. Kohsaka H, Carson DA. Solid-phase polymerase chain reaction. J Clin Lab Anal 1994;8:452-55
45. Mohapatra G, Kim DH, Feuerstein BG. Detection of multiple gains and losses of genetic material in ten glioma cell lines by comparative genomic hybridization. Genes Chrom Cancer 1995; 13:86-93
46. Piper J, Rutovitz D, Sudar D, et al. Computer image analysis of comparative genomic hybridization. Cytometry 1995;19:10-26
47. Fischer U, Wullich B, Sattler HP, Göttert E, Zang KD, Meese E. DNA amplifications on chromosomes 7, 9 and 12 in glioblastoma detected by reverse chromosome painting. Eur J Cancer 1994;30A, 1124-27
48. Reifenberger G, Reifenberger J, Ichimura K, Collins VP. Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site. Cancer Res 1995;55:731-34
49. Stark GR. Regulation and mechanisms of mammalian gene amplification. Adv Cancer Res 1993;61:87-113
50. Park SH, Maeda T, Mohapatra G, Waldman FM, Davis RL, Feuerstein BG. Heterogeneity, polyploidy, aneusomy, and 9p deletion in human glioblastoma multiforme. Cancer Gen Cytogen 1995;83:127-35